canada semaglutide patent Generic versions of weight-loss drugs should arrive on Canadian pharmacy shelves this summer Ozempic's patent problem: how Novo

While the FDA has shown no signs of moving toward over-the-counter status for semaglutide or tirzepatide, PlexusDx offers a more accessible alternative to traditional pharmacy channels today

Nausea, for example, was reported by 18% to 22% of tirzepatide users (depending on the dose) compared to 18% of semaglutide users

The medication slows gastric emptying, reduces hunger signals, and helps stabilize glucose levels throughout the day

This is where psychiatrists and PMHNPs have an edge over purely transactional telehealth platforms: you understand behavior change and can integrate mental health support for patients whose eating is driven by depression or anxiety